So much of share buy back

Got Covid , No Covid, Got Vaccine, No vaccine..... people still have to wear mask . Whether or not PRLEXUS can give good fortune for u, you decide. Last time TP was given at RM2.75. Buy/Sell at your own risk. All the best guys.

Lol

NPRA1985, go get a life. U are in every single forum to give negative comments. Well, ya you can say whatever you like but remember ,remember, what goes around comes around. Believe me.

Mask and glove are two different story. At the beginning of October 2020, PRLEXUS share price surge due to strong earnings and leave the glove sectors behind. Study the history properly.

肯定会上！

I bought Bintai Solutn and Yongtai at some price, made some profit and exit. MYEG is not a Vaccine goreng stock, but strong fundamental, nice dividend, decent EPS, i will keep this till next year

The only Vaccine-related stock which hasn't FLY UP KAO KAO like BINTAI, SOLUTN and YONGTAI

So what's the hurry to sell your stock? Once JAKIM cert is obtained, SKY is the limit

MyEG: Inks three-year cooperation with Zhifei to obtain JAKIM certification, distribute Covid-19 vaccine. MyEG Services (MyEG) has entered into a cooperation with Anhui Zhifei Longcom Biopharmaceutical Co Ltd (Zhifei), via a MoU, to obtain Malaysian halal certification for the Chinese biopharma company’s Covid-19 vaccine and to exclusively distribute the vaccine in Malaysia for a three-year period. The commencement of the Phase 3 trials will make Zhifei’s vaccine one of the first to undergo the final-stage trials in Malaysia, under the purview of the Ministry of Health (MoH). (The Edge)

Collected more at 1.68...1.69 !!!

Yong Tai to collaborate with Chinese company in Covid-19 vaccine development, distribution in Malaysia

theedgemarkets.com

December 04, 2020 21:22 pm +08

KUALA LUMPUR (Dec 4): Property developer Yong Tai Bhd has entered into a heads of agreement (HoA) with China-based Shenzhen Kangtai Biological Products Co Ltd (SZKT) for a proposed collaboration on the development and exclusive commercialisation of the latter's inactivated Covid-19 vaccine in Malaysia.

SZKT is currently developing a Covid-19 Inactivated Vaccine (Vero Cells) against the coronavirus,according to Yong Tai in a stock exchange filing today. Under this collaboration, Yong Tai will be SZKT's partner in Malaysia to conduct Phase III clinical trials and exclusive commercialisation of the vaccine.

To support this collaboration, Yong Tai said it has also entered into an advisory and service agreement (ASA) with Klinsel Sdn Bhd to appoint Klinsel as the Contract Research Organisation (CRO) for the proposed clinical study of the Covid-19 vaccine to be conducted in Malaysia.

Upon the successful conclusion of the Phase III clinical trial or emergency usage approval being obtained in Malaysia, whichever is earlier, Yong Tai said the parties plan to cooperate on a vaccine procurement programme of approximately 100 million doses of the vaccine over a five-year period, of which the committed quantity for the first three years shall be not less than 20 million doses per annum.

"Yong Tai believes that the proposed partnership is in the best interests of the company and its shareholders, because of the diversification of revenue stream through the sale and distribution of vaccines in light of the Covid-19 pandemic," Yong Tai's filing read.

"Barring any unforeseen circumstances, the proposed collaboration is expected to contribute positively to YTB’s revenue in the future," Yong Tai added.

SZKT, which is listed on the Shenzhen Stock Exchange, is principally involved in developing and manufacturing human vaccines. It has more than 30 kinds of vaccines under development, according to Yong Tai.

Meanwhile, Kinsel is a CRO that offers a comprehensive package of research services for the pharmaceutical and biotech industry.

Patience is gold. Next wave RM0.65.

Sigh...it was RM1.75 in 2017...overlooked

the wave is very clear now. Its all about vaccine. Face it and dare to ride on this wave if u missed glove & healthcare stock few months ago.

NPRA1985 Pity those stuck at 1.40... Do u still remember your statement ah? Now i feel pity for u

@NPRA1985 Long time didn't hear from u. Just wonder do u still have the sour taste in your mouth ah?

@DickyMe, eh what's your problem lah?

@DickyMe you are the best :)

@NPRA1985 Who is the Noob now? lol KIKIKI

NPRA1985 OMG, at almost 1am, you are still bashing comments and asking people to be aware of vaccine stocks. Really Salute you. You are the best ~!

Becareful ,becareful becareful, Supermax, Topglove, Comfort, LKL, HLT.....All because of becareful

DickyMe , emil, NPRA1985, Thanks for your kind reminder towards those who bought this share. But sorry. We see the potential in it and have decided to move higher. Win or lose has nothing to do with you. Those who curse about limit down, you will have the same in your stock portfolio. Like i said, fengshui turn around, karma goes around.

You made all your effort to warn people regarding the recent surge in Vaccine related stocks. Which is good. But too much of an effort looks like a sour grape to me. No hard feelings.

人生没有一搏， 跟咸鱼什么区别？ 赚钱是看到一般人看不到的前途，钱途。

Agree with u joyvest. Feng Shui turn around, ride with the wave. Or else, You will never get a chance like Supermx and now Vaccine stock. Do Your own homework.

IF AMERICAN GIVES A "BUY CALL" FOR CANSINO, WHY NOT MALAYSIA BANK GIVE A "BUY IN" CALL FOR SOLUTION ? THINK

COMPANY WITH IMPROVING EARNINGS, PLUS A POTENTIAL UPSIDE DUE TO THE COVID VACCINE. WHAT ELSE YOU WANT? TELL ME .

You need to understand that this stock is really different from GETS/EURO/VIVOCOM. Company is earning money, having a CEO Datuk who is pioneer of biotechnology potential in developing biotechnology stuff as well as involving themselves in Vaccine business.

I don't understand some people here like to curse limit down...drop to hell things like that. Did they actually go to various forum which share price have soar and curse them like what they did ? Wow, how pathetic their life is...

Spring is better than Wegmans.. but, lower share price ....

Vaccine stock wil rise like Supermax, Topglove, etc. Feng Shui Turn around.

Furniture stocks have been quiet for quite some time...

Dato' Dr. Mohd Nazlee bin Kamal, Ph.D. is Deputy Managing Director, Executive Director of the Company. From 1986 - B. Sc. Chemical Engineering, Oregon State University, USA
2. 1989 - M. App. Sc. Biotechnology, University of New South Wales, Australia
3. 1996 - PhD. Chemical Engineering, University of Queensland, Australia
4. Member of International Society for Pharmaceutical Engineering
5. Member of Institution of Chemical Engineers Malaysia
6. Member of Microbiology Society.

From 2015-2016 Member of National Blue Ocean Strategy Committee 2011-2016 Chairman/Director, Malaysian Bio-XCell Sdn Bhd 2014-2016 Director, Johor Biotechnology & Biodiversity Corporation 2014-2016 Director, Malaysian Global Innovation and Creativity Centre (MAGIC) 2012-Present Director, National Institutes of Biotechnology Malaysia (NIBM) 2012-2016 Director, Melaka Biotechnology Corporation 2011-2016 Director, Malaysian Biotechnology Corporation Sdn Bhd 2011-2016 Director, BiotechCorp Investment Holding Sdn Bhd 2011-2016 Director, BiotechCorp Technology Management Sdn Bhd 2011-2015 Director, Malaysia Forestry Research and Development Board (MFRDB) 2012-2016 Taskforce Member, 1Malaysia Biomass Alternative Strategy (1MBAS) 2014-2016 Council Member, Malaysian Standards and Accreditation Council (MSDAM) 2011-2016 Council Member, National Innovation Council (NIC) 2011-2016 Ex-officio, Global Science and Innovation Advisory Council (GSIAC) 2015-Present Member, Advisory Council for German-Malaysian Society e.V (DtMG) 2011-2016 Member, Advisory Panel for NCIAs Plant Science and Tissue Culture Node (PSTCN) 2014-2016 Member, Advisory Panel for School of Biological Sciences, Universiti Sains Malaysia 2011-2016 Steering Committee, Agriculture NKEA 2002-2011 Director, Inno Bio Ventures Sdn Bhd 2002-2011 Director, Inno Biologics Sdn Bhd

Must see lah who is the Datuk CEO inside the company. Main - main ah? bukan calang calang o..

BORING....PARK HERE FIRST. SEE U NEXT YEAR

QoQ 1811.32%

WOW, Strong earnings . Quaterly report just released

Guys just ignore . The more u response to dog bark, the dog gets even more excited

omg.... kHATULISTIWA1234, U go to people's forum and curse like this, ur God won't punish people like you ?

With the rising cases of Covid 19, test kit ....remember....demand and supply.

VIVOCOM = TIMECOM

VIVOCOM = TIMECOM .

They don't sell vaccine. They will be distributor for the vaccine to General practitioner and doctors. Listen to doctor lah. RM4.50 is coming

RM1.13 tomorrow, RM4.50 by Feb2021

See you at RM0.75

Vaccine will be available in the market very very soon. By then , you will never get this price.

Dow soars more than 1,000 points after Pfizer announces great news about its vaccine and Joe Biden declared victorious

New York (CNN Business)US stocks surged Monday, after Pfizer said its Covid-19 vaccine is 90% effective, and Joe Biden was projected to be the winner of the presidential election over the weekend.

The Dow (INDU) was up as many as 1,610 points before paring some of its gains. The index was last up 1,260 points, or 4.4%.

At this rate, the Dow is on pace for one of its best days of the year and one of its biggest daily point gains in history. The index is also on track to overtake its February all-time closing high and has already set a new intraday record high.

The broader S&P 500 (SPX) jumped 3.3%. It is also on track for a record high, as well as its best day since April.

The Nasdaq Composite (COMP) also opened higher, jumping 1.3%, but the tech-heavy index is lagging behind as many tech stocks that benefited during stay-at-home orders went into reverse.

The Nasdaq is still below its September record, but it's not far off.
Pfizer's much-better-than-expected vaccine efficacy announcement, albeit an early look at its data, is just what Wall Street had been hoping for. The coronavirus pandemic has caused historic economic turmoil across the globe, and cases are surging to new records every day. That threatens to tip the scales and send the US economy heading in the wrong direction once again.

Although the vaccine is not set to be widely administered soon, Pfizer said it plans to seek emergency use authorization from the US Food and Drug Administration soon after volunteers have been monitored for two months following their second dose of the vaccine.

The drugmaker's CEO Albert Bourla said Monday that the company expects to have 1.3 billion doses of the vaccine globally next year, on top of 50 million doses this year. Two separate production lines, one in the United States and one in Europe, will make the vaccine.

Pfizer's (PFE) stock surged 14.1% at the open.
The vaccine news was good for pharmaceutical stocks, including Dow components Merck and Johnson & Johnson, both of which were higher before the bell.

the explanation is basically Vaccine.

where is @wallstreet777? Woke up already ?